Platinum alkylating agent

DRUG CLASS:

News alerts, weekly reports and conference planners

SAMHD1 expression	Ovarian Cancer	SAMHD1 expression	Ovarian Cancer	Platinum alkylating agent Resistant: C3 – Early Trials Platinum alkylating agent Resistant : C3	Platinum alkylating agent Resistant: C3 – Early Trials Platinum alkylating agent Resistant : C3
SAMHD1 expression	Non Small Cell Lung Cancer	SAMHD1 expression	Non Small Cell Lung Cancer	Platinum alkylating agent Resistant: C3 – Early Trials Platinum alkylating agent Resistant : C3	Platinum alkylating agent Resistant: C3 – Early Trials Platinum alkylating agent Resistant : C3
SAMHD1 expression	Ovarian Cancer	SAMHD1 expression	Ovarian Cancer	Platinum alkylating agent + gemcitabine Resistant: C3 – Early Trials Platinum alkylating agent + gemcitabine Resistant : C3	Platinum alkylating agent + gemcitabine Resistant: C3 – Early Trials Platinum alkylating agent + gemcitabine Resistant : C3
EGFR exon 20 insertion	Non Small Cell Lung Cancer	EGFR exon 20 insertion	Non Small Cell Lung Cancer	Platinum alkylating agent Sensitive: C3 – Early Trials Platinum alkylating agent Sensitive : C3	Platinum alkylating agent Sensitive: C3 – Early Trials Platinum alkylating agent Sensitive : C3

Associations(4)